Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

Published:2019-04-30 Issue: Volume: Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Tschautscher Marcella A.¹^ORCID,Jevremovic Dragan²,Rajkumar Vincent³^ORCID,Dispenzieri Angela³,Lacy Martha Q.³,Gertz Morie A.³^ORCID,Buadi Francis K.³,Dingli David³,Hwa Yi L.³,Fonder Amie L.³,Hobbs Miriam A.³,Hayman Suzanne R.³,Zeldenrust Steven R.³,Lust John A.³,Russell Stephen J.⁴,Leung Nelson⁵^ORCID,Kapoor Prashant³,Go Ronald S.³,Lin Yi³,Gonsalves Wilson I.³^ORCID,Kourelis Taxiarchis³^ORCID,Warsame Rahma³^ORCID,Kyle Robert A.³,Kumar Shaji K.³

Affiliation:

1. Division of Internal MedicineMayo Clinic Rochester Minnesota

2. Division of HematopathologyMayo Clinic Rochester Minnesota

3. Division of HematologyMayo Clinic Rochester Minnesota

4. Division of Hematology and Molecular MedicineMayo Clinic Rochester Minnesota

5. Division of Nephrology and Hypertension, Department of Internal MedicineMayo Clinic Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25481

Reference21 articles.

1. Clinical course and outcomes of patients with multiplmyeloma who relapse after autologous stem cell therapy;Gonsalves WI;Bone Marrow Transplant,2016

2. Minimal residual disease in multiple myeloma;Munshi NC;J Clin Oncol,2013

3. Consensus recommendations for risk stratification in multiple myeloma: report of the international myeloma workshop consensus panel 2;Munshi NC;Blood,2011

4. International myeloma workshop consensus on risk stratification in multiple myeloma;Chng WJ;Leukemia,2013

5. International myeloma working group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem‐cell transplantation;Palumbo A;J Clin Oncol,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma;Leukemia;2024-08-02

2. Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients;International Immunopharmacology;2024-03

3. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: update on laboratory tests for the study of monoclonal gammopathies;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-24

4. Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future;Cancers;2023-07-20

5. Diagnostic and Prognostic Value of PACAP in Multiple Myeloma;International Journal of Molecular Sciences;2023-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3